Hebert Adelaide A, Bogle Melissa A
Department of Dermatology, The University of Texas Health Science Center, Houston, Texas 77030, USA.
J Am Acad Dermatol. 2004 Feb;50(2):286-8. doi: 10.1016/j.jaad.2003.07.017.
Human intravenous immunoglobulin has been described as a treatment for patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. We describe the prophylactic use of intravenous immunoglobulin to prevent Stevens-Johnson syndrome in a woman undergoing cardiac catheterization with a previous history of four episodes of Stevens-Johnson after receiving intravenous contrast dye.
